Lilly's announcement that it would make its experimental weight-loss pill in the U.S. comes amid administration pressure on ...

By making the expected blockbuster pill in the U.S., Lilly may be able to avoid the impact of Trump’s sweeping tariffs, ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

Eli Lilly said its experimental drug, orforglipron, helped people with Type 2 diabetes lower their blood sugar and lose ...

A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at ...

A DAILY weight loss pill that works like Ozempic has succeeded in a major clinical trial. Patients lost an average of a stone and two pounds (7.3kg) each over 10 months. Unhealthy blood sugar ...

Imagine a world where managing type 2 diabetes doesn't involve needles. A new experimental pill might just change the game, ...

That's good news for Recursion Pharmaceuticals ( RXRX 3.67%), a biotech company that's already pioneering the use of AI in drug development. Recursion's shares soared on the news, but the stock ...

CDMOs Expand Capabilities Amid Surge in Clinical Trials and Demand for Orphan Drugs and Novel TherapiesDublin, April 18, 2025 (GLOBE NEWSWI ...

Delta 8 and 10 products tend to be lab made, as these cannabinoids contain less natural THC than Delta 9, which is regulated ...

What a difference five years can make. Just look at Eli Lilly (NYSE: LLY). In April 2020, the drugmaker stood in the shadows ...

Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...